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a b s t r a c t 
Synapsin 1 (SYN1) is a phosphoprotein involved in nerve signal transmission. The porcine SYN1 pro-
moter orthologue was cloned and characterized to provide a means of expressing a transgene speciﬁcally
in neurons. The nucleotide sequence of the promoter displayed a high degree of conservation of ele-
ments responsible for neuron-speciﬁc expression. Expression analysis of SYN1 demonstrated presence
of transcript during embryonic development. Analysis of GFP expression in transgenic zebraﬁsh em-
bryos suggests that the pig SYN1 promoter directs expression in neuronal cells. Thus, the SYN1 promoter
is a good candidate for use in the generation of pig models of human neurodegenerative disorders. 
C © 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical
Societies. Open access under CC BY license. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1. Introduction 
Synapsin 1 (SYN1) belongs to a family of phosphoproteins, also
comprising synapsin 2 and 3 with isoforms. These synapsins as-
sociate with the surface of synaptic vesicles [ 1 , 2 ]. Members of the
synapsin family have common protein domains and are implicated in
neuronal development, synaptogenesis, and maintenance of mature
synapses and modulation of neurotransmitter release [ 3 ]. Synapsins
regulate synaptic vesicle trafﬁc and are also involved in the regulation
of synaptic vesicle availability for release and in short-term plasticity.
Two different carboxy-terminal forms of SYN1, a and b, exist, origi-
nating from alternative splicing of a common transcript. Well-known
from a number of vertebrate species, SYN1 is an important player  The sequences of the porcine SYN1 promoter and the SYN1 genomic sequence have 
been submitted to DDBJ / EMBL / GenBank under the accession numbers GQ168794 and 
JN673714 , respectively. 
Abbreviations: Ab, antibody; BSG, basal ganglia; BST, brain stem; CBE, cerebellum; 
Chr, chromosome; CMV, cytomegalovirus; FB, forebrain; FCO, frontal cortex; GFP, green 
ﬂuorescent protein; HB, hindbrain; HIP, hippocampus; LLG, lateral line ganglion; MB, 
midbrain; NRSE, neuron restrictive silencer element; OC, optic chiasm; ON, olfactory 
neuron; R, retina; REST, RE1-silencing transcription factor; TG, trigeminal ganglion; 
TSS, transcription start site; WPRE, Woodchuck hepatitits virus Post-transcriptional 
Regulatory Element. 
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http://dx.doi.org/10.1016/j.fob.2013.10.002 in neurotransmitter release, axonogenesis and synaptogenesis illus-
trated by knockout mice presenting with an epileptic phenotype [ 4 , 5 ].
Binding to small synaptic vesicles found in the nerve terminals, SYN1
possibly has an exocytotic regulatory role in linking the vesicles to
the cytoskeleton and each other [ 6 –8 ]. Furthermore, SYN1 is likely
involved in neuronal development and formation of synaptic con-
tacts between neurons [ 9 –11 ]. Mutations in the SYN1 gene have been
demonstrated to be associated with epilepsy [ 12 ] and autism spec-
trum disorders with or without epilepsy [ 13 ]. The mutations create
changes in the SYN1 protein thereby potentially causing defects in
synaptic vesicle trafﬁc and nerve terminal function. In accordance
with its native function, SYN1 is found to be brain- and neuron-
speciﬁcally expressed mediated by the promoter region of the SYN1
gene [ 14 ]. The SYN1 protein serves as a substrate for several different
protein kinases and phosphorylation is very likely functioning in the
regulation of this protein in the nerve terminal. 
In transgenesis, direction and limitation of gene expression to
neurons have been demonstrated with the SYN1 promoter [ 15 –20 ].
Though being highly speciﬁc, the SYN1 promoter appears relatively
weak which has prompted a down-stream addition of a Woodchuck
hepatitis virus Post-transcriptional Regulatory Element (WPRE). The
resulting transgene expression cassette exhibits retained neuronal
speciﬁcity and a considerably elevated level of expression of two-
threefold [ 21 , 22 ]. High levels of transgene expression are often strived
for e.g. in generation of animal models for human diseases to rapidly
introduce a disease phenotype. Such expression levels can in gen-
eral be obtained with viral promoters as that of the widespread hu-
man cytomegalovirus (CMV) but constitutive expression, which isan Biochemical Societies. Open access under CC BY license.
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Bndesirable in some studies, and frequent gene silencing are other 
haracteristics of the CMV promoter [ 23 –26 ]. The utilization of an 
ndogenous promoter would likely overcome the challenge of exo- 
ene silencing [ 27 –29 ] and, hence, secure stable long-term transgene 
xpression [ 23 ] presumably required for inducing phenotypes of e.g. 
ge-related, neurodegenerative disorders. Several human diseases of 
his kind have been modelled in rodents, particularly mice, but im- 
rovements are sought for using primates [ 30 –32 ] and, more recently, 
igs [ 33 ], as use of swine generally does not face the substantial public 
oncerns related to the use of primates as laboratory animals. In ad- 
ition, characterization of the porcine genome provides evidence of a 
lose genetic relationship between humans and pigs which together 
ith the well-known anatomic and physiological similarities points 
o the pig as a good species for modelling human diseases not least 
hose of the central nervous system. 
Altogether this has prompted us to clone the porcine SYN1 pro- 
oter and characterize the expression pattern and cell speciﬁcity 
xpected from transgene constructs including this promoter. 
. Materials and methods 
.1. Ethic statements 
The pigs were housed and used in compliance with European Com- 
unity animal care guidelines. Beforehand, the experimental proce- 
ures were approved by the National Ethical Committee in Denmark 
Approval No. 2010 / 561-1891). Pigs were sacriﬁced by an injection 
ith 30 mg / kg Pentobarbital (Vipidan, Denmark). Experiments in- 
olving zebraﬁsh were carried out in accordance with the recom- 
endations from the European network on ﬁsh biomedical models 
nd according to Danish legislation. All zebraﬁsh used in this study 
ere under the age of 72 h and hence the experiments do not require 
ny approval. Zebraﬁsh embryos were killed by a tricaine overdose. 
.2. Biological subjects 
The study included pig embryos sampled at 60, 80, 100, and 
15 days of gestation. Five different brain areas were included in this 
tudy: cerebellum (CBE), frontal cortex (FCO), brain stem (BST), basal 
anglia (BSG) and hippocampus (HIP). Three separate tissues were 
pplied for each type of brain tissue and time in gestation, yielding 
 total of 60 samples. Brain tissue samples were also collected from 
hree Danish Landrace pigs, aged 1–2 years and weighing 125–200 kg. 
.3. Cloning of the SYN1 promoter 
The 5 ′ -ﬂanking sequence of the human SYN1 gene (GenBank: 
55301 ) was compared to preliminary porcine genomic data which 
dentiﬁed a homologous sequence from which a forward primer 
PromFW 5 ′ -AAAGGGATGGGGGCGTAC-3 ′ ) was designed. The corre- 
ponding reverse primer (PromRV 5 ′ -ATGAAGTTGCTGTCCGACAG-3 ′ ) 
as derived from the putative exon 1 of a porcine EST sequence dis- 
laying homology to the human SYN1a encoding sequence (GenBank: 
M 006950 ) (DNA Technology, Aarhus, Denmark). For ampliﬁcation 
f the promoter, porcine genomic DNA puriﬁed from boar semen was 
sed as template in a PCR with a Long PCR Enzyme Mix applied to- 
ether with the standard buffer (Fermentas, Glen Burnie, MD) and the 
emperature conditions: 94 ◦C for 30 s; 35 cycles of 94 ◦C for 10 s, 
4 ◦C for 30 s, and 68 ◦C for 1.30 min; 68 ◦C for 10 min. The amplicon
as cloned in electrocompetent One-Shot Escherichia coli with the TA 
OPO Cloning Kit from (Invitrogen, Carlsbad, CA). Complete Sanger 
equencing of the insert in both directions using a Big Dye Termina- 
or Cycle Sequencing Kit and an ABI 3730 xl DNA Analyzer (Applied 
iosystems, Warrington, UK) was carried out by primer walking. 2.4. Expression analysis of SYN1 
Splice variants of SYN1 (a and b) described in other species have 
also been found in the pig [ 34 ] and enabled the design of PCR 
primers discriminating between the two isoforms ( Fig. 1 ). A SYN1a - 
speciﬁc reverse primer (CdsRVa 5 ′ -AGGCATTGGTCAGAGACTGGG-3 ′ ) 
was placed in the 5 ′ terminal, unique part of exon 13 whereas a 
syn Ib-speciﬁc reverse primer (CdsRVb 5 ′ -GGGGCTGGCTTTGAGCTG- 
3 ′ ) spanned the junction between exon 12 and the trun- 
cated exon 13. A generic forward primer in exon 12 (Cds- 
FWab 5 ′ -GTCCCACCAAGCCACAGCT-3 ′ ) was used with both of 
the reverse primers (DNA Technology, Aarhus, Denmark) and 
a common 5 ′ -GCCTGCTG-3 ′ LAN probe (#40, Human Probe Li- 
brary, Exiqon) detected both SYN 1a and 1b amplicons. GAPDH 
served as reference gene for normalization of data due to its 
appropriateness found in an evaluation with other candidate 
genes [ 35 ]. Primers (GAPDHFW 5 ′ -GACTCATGACCACGGTCCATG-3 ′ , 
GAPDHRV 5 ′ -GTCAGATCCACAACCGACACG-3 ′ ) ampliﬁed a fragment 
of the GAPDH coding sequence detected with the probe 5 ′ -VIC- 
CATCACTGCCACCCAGA-3 ′ . 
Total RNA was puriﬁed from frontal cortex (FCO), cerebellum 
(CBE), brain stem (BST), hippocampus (HIP), and basal ganglia (BSG) 
from pig foetuses recovered 60, 80, 100, and 115 days post artiﬁ- 
cial insemination, respectively. cDNA was synthesized with the re- 
verse transcriptase Superscript III primed by random hexameric nu- 
cleotides (Invitrogen, Carlsbad, CA). The cDNA libraries were used as 
templates in real-time PCRs quantifying SYN1a , SYN1b , and GAPDH 
transcripts, respectively, in a TaqMan based assay. The cDNA prepa- 
ration from frontal cortex at 115 days was diluted 2, 4, 8, 16, and 32 
times to produce a series for semi-quantitative calculations. 
The equality of SYN1a and SYN1b expression levels between dif- 
ferent times of gestation within the ﬁve sampled tissues was tested 
for statistical signiﬁcance using the standalone software REST [ 36 ]. 
The statistical model applied was the Pair Wise Fixed Real location 
Randomization Test. The assumption regarding normal distribution of 
the data was avoided and differences in expression between groups 
were assessed using the means for statistical signiﬁcance by ran- 
domization. The level of probability was set at P < 0.05 as statistical 
signiﬁcance and 50,000 randomization steps were implemented in 
each comparison. 
2.5. Engineering of SYN1 DNA constructs for zebraﬁsh transformation 
The Tol2-SYN1promoter:GFP plasmid was constructed based on 
the pT2AL200R150G vector kindly provided by Koichi Kawakami, 
National Institute of Genetics, Japan [ 37 , 38 ]. The restriction en- 
zymes Xho I and Hin dIII (New England BioLabs) were used to re- 
place the EF1a-promoter, originally placed in the pT2AL200R150G 
vector, with the porcine SYN1 promoter. Using PCR, linkers for sub- 
sequent cloning were added to the porcine SYN1 promoter sequence 
(GQ168794). PCR was carried out with the primers: pSYN1- Xho I: 5 ′ - 
CCGCTCGAGCGGAGACCAAATGTGTGTGTGTAG-3 ′ and pSYN1- Hin dIII: 
5 ′ -CCCAAGCTTGGGGCGGCGCCGCAGGTAGTTCATG-3 ′ . The ampliﬁed 
product was cloned into a TOPO vector (Invitrogen) and digested with 
the restriction enzymes Xho I and Hin dIII. The SYN1 insert was cloned 
into a Xho I and Hin dIII digested pT2AL200R150G vector. 
In order to substitute the nucleotide A with a C in position 
−230, i.e. 230 nucleotides upstream of the transcription start site, 
of the porcine SYN1 promoter sequence (GQ168794), an equivalent 
to position site-directed mutagenesis was performed employing 
the QuickChange ® XL Site-Directed Mutagenesis Kit (Stratagene). 
PCR was accomplished in accordance with the manufacturer’s 
recommendation applying the following primers: SYNP-MUTF: 
5 ′ -GCGCACTGTCGTCTTC C GCACCGCGGACAGCGC-3 ′ and SYNP- 
MUTR: 5 ′ -GCGCTGTCCGCGGTGC G GAAGACGACAGTGCGC-3 ′ and the 
pT2AL200R150G vector harbouring the SYN1 promoter. The PCR 
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Fig. 1. Parts of exon 12 and 13 in the 3 ′ end of porcine SYN1a and SYN1b coding sequences. For expression analysis of the two separate mRNAs, a qPCR assay was designed. The 
forward primer (FWab) and probe were common to both messengers whereas speciﬁc reverse primers (RVa and RVb) were created for discrimination of the mRNAs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 conditions were: Denaturation at 95 ◦C for 1 min, 18 cycles of 95 ◦C
for 50 s, 60 ◦C for 50 s and 68 ◦C for 2 min. The PCR program was
concluded by an extension at 68 ◦C for 7 min. To ensure that the
mutation of interest was integrated in the porcine SYN1 promoter,
several colonies were picked and grown overnight and plasmids
were harvested and sequenced according to standard procedures.
Plasmid DNA for microinjection was puriﬁed from a culture of trans-
formed DH5a cells (Invitrogen) using the QIAprep Spin Miniprep Kit
(Qiagen). 
The resulting SYN1 constructs, Tg(pSYN1:GFP) = SYN1pwt
( −230A) and Tg(pSYN1Mut:GFP = SYN1pMut ( −230C) were used for
transformation of zebraﬁsh. 
2.6. Handling of zebraﬁsh 
Zebraﬁsh of the AB strain were obtained from the T ¨ubingen ze-
braﬁsh stockcenter. The ﬁsh were fed twice a day and kept at 28.5 ◦C
on a 14 h light / 10 h dark cycle. The embryos were obtained by natural
crosses, reared in E3 buffer (5 mM NaCl, 0.17 mM KCl, 0.33 mM MgSO 4 ,
10 −5 % methylene blue, 2 mM Hepes pH 7.0), and staged according to
Kimmel et al. [ 39 ]. Upon completion of gastrulation, the E3 buffer
was supplemented with 0.003% N -phenylthiourea (PTU) (SIGMA) to
inhibit pigmentation. 
2.7. Preparation of Tol2 transposase mRNA 
The pCS-zT2TP plasmid [ 37 , 38 ] kindly provided by Koichi
Kawakami, National Institute of Genetics, Japan, was linearized with
NotI and used as a template for in vitro transcription of the Tol2 trans-
posase mRNA. Capped mRNA for microinjection was synthesized us-
ing the mMessage mMachine SP6 Kit (Ambion, Inc.). The RNA syn-
thesis reaction was treated with TURBO DNase (Ambion) followed
by puriﬁcation using the RNeasy MinElute Cleanup Kit (Qiagen). RNA
quality was assessed by denaturing RNA gel electrophoresis using the
FlashGel System (Lonza), and RNA content was quantiﬁed by spec-
troscopy. 
2.8. Micro-injection of zebraﬁsh and GFP expression 
Micro-injection volumes were measured and calibrated by per-
forming 10 injections into a 0.5 μL microcapillary tube (Drummond
Microcaps), measuring the amount of liquid using a ruler, and calcu-
lating the volume per injection. Five nanoliters of injection mixture
containing 50 pg Tol2 transposase encoding mRNA and 100 pg Tol2-
SYN1promoter:GFP plasmid were microinjected into the centre of the
yolk of zebraﬁsh zygotes. 
For microscopy, live embryos were sedated with 150 ng / mL tri-
caine (Aldrich) in E3 / PTU and mounted in 1.5% hydroxypropyl methyl
cellulose M n 86000 (Sigma–Aldrich). GFP expression in zebraﬁsh live
embryos and larvae was documented using a Zeiss AXIO Observer.D1
microscope equipped with Zeiss Colibri Illumination System and Zeiss
AxioCam MRm. Fluorescence microscopy of immunostained embryos
was documented using a Zeiss AXIO Observer.Z1 equipped with Zeiss
Colibri .2 Illumination System, Zeiss Apotome .2, and Zeiss AxioCam
HRm. Images were stacked and Z-projections were made in ImageJ.Contrast and brightness of Z-projections were adjusted and the re-
sulting images were merged in Adobe Photoshop CS5. 
2.9. Whole mount immunohistochemistry 
Zebraﬁsh embryos were euthanized, ﬁxed and immunostained
as described previously (REF: PMID 23430244 ). Primary antibod-
ies: Ab1-tuba (6-11B-1, Sigma–Aldrich) (1:2000) and anti-GFP, rabbit
polyclonal antibody, unconjugated (Invitrogen) (1:500). Secondary
antibodies: Alexa Fluor 555 donkey anti-mouse (Invitrogen) (1:1000)
and Alexa Fluor 488 goat anti-rabbit (Invitrogen) (1:1000). 
2.10. Detection of transgene 
The upper half of the tail-ﬁn was cut from potential transgenic and
control zebraﬁsh and stored at −20 ◦C in RNA later ® reagent (Am-
bion). Genomic DNA and RNA of tail ﬁn cuts from eleven transgenic
zebraﬁsh and two controls were extracted using TriReagent (SIGMA). 
Synthesis of cDNA was conducted with 750 μg of total RNA iso-
lated from the tail ﬁn using SuperScript III RNase H − reverse tran-
scriptase (Invitrogen) and random hexamer primers according to the
manufacturer’s recommendations. 
Detection of the transgene was performed by PCR ampliﬁcation of
fragments covering the GFP gene and the porcine synapsin promoter
sequence. PCR reactions were done according to standard protocols
in a volume of 10 μl with ng DNA, 1 μM of each primer, 0.5 mM dNTP
and x0.2 U Phusion DNA polymerase (Finnzymes). 
Primers used to amplify the GFP fragment (720-bp) were
GFP-PS-F: 5 ′ -ATGGTGAGCAAGGGCGAGG-3 ′ and GFP-PS-R: 5 ′ -
TTACTTGTACAGCTCGTCCATGCC-3 ′ . 
Primers used to amplify the SYN1 promoter sequence
(576 bp) were: SYNPp1f: 5 ′ -CGTGAGTGTAGGCAGGCATGCCCAT-3 ′ 
and SYNPp1r: 5 ′ - ATGCGCAATTTGGGGAGTGGGGGCGG -3 ′ . The PCR
conditions were: Denaturation at 98 ◦C for 30 s, 10 cycles of touch-
down ( −0.5 ◦C / cycle) 98 ◦C for 30 s, 65–60 ◦C for 30 s and 72 ◦C for
1 min 35 s, 25 cycles 98 ◦C for 30 s, 60 ◦C for 30 s, 72 ◦C for 1 min 35 s,
The PCR program was concluded by a 7 min extension at 72 ◦C. 
The RT-PCR reaction mix contained: 0.1 μL cDNA,
1.5 mM MgCl 2 , 0.5 mM dNTP, 0.5 μM of each primer GFP-
PS-F: 5 ′ -ATGGTGAGCAAGGGCGAGG-3 ′ and GFP-PS-R: 5 ′ -
TTACTTGTACAGCTCGTCCATGCC-3 ′ and 1 U Phusion DNA polymerase
(Finnzymes) in a total volume of 10 μL. The PCR proﬁle was as
follows: 98 ◦C for 30 s, 10 touchdown cycles of 98 ◦C for 30 s, 68 ◦C
for 30 s, 72 ◦C for 1 min 35 s, followed by 25 cycles of 98 ◦C for 30 s,
63 ◦C for 30 s, 72 ◦C for 1 min 35 s and ﬁnally an elongation at 72 ◦C
for 7 min. 
2.11. Methylation status of SYN1 
In brief, the methylation status of SYN1 was performed by library
preparation, sequencing, mapping and analysis. DNA from each sam-
ple was extracted and sheared to a size of 200–300 bp using the Co-
varis Adaptive Focused Acoustics TM (AFA) process (Covaris). Double-
stranded DNA fragments were end repaired, A-tailed, and ligated to
methylated Illumina adaptors. Ligated fragments were bisulﬁte con-
verted using the EZ-DNA Methylation-Kit (Zymo research). Following
414 Claus Hedegaard et al. / FEBS Open Bio 3 (2013) 411–420 
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bCR enrichment, fragments of 325–425 bp were size selected and 
equenced using Hiseq 2000 Illumina sequencing system. 
We used Novoalign short read aligner (version 2.07.12 
ttp: // www.novocraft.com / ) to align reads to a reference 
enome. Novomethyl (Beta.8.0 http: // novocraft.com / main / 
age.php?s = novomethyl ) was used to call the consensus se- 
uence, identify cytosines and call their methylation state or 
ercentage of cytosines methylated. For ﬁnding the methylation 
ercentage of special genes or sequences from our methylome data 
le, we used Tabix [ 40 ]. 
.12. Analysis of DNA methylation in pig brain at two developmental 
tages 
DNA was isolated from sections of cerebellum and frontal cortex 
ollected from pig brain at 60 days of gestation and from an 11-year- 
ld pig, both Danish Landrace. Genomic DNA from snap-frozen brain 
amples was extracted using a standard protocol. One microgram of 
NA was bisulﬁte modiﬁed using the EZ DNA Methylation Kit (ZYMO 
esearch Group). Modiﬁed DNA was puriﬁed using the EZ Bisulﬁte 
NA Clean-up Kit (ZYMO Research Group). 
Bisulﬁte sequencing was carried out on a 104 bp SYN1 se- 
uence. Bisulﬁte modiﬁed DNA was PCR ampliﬁed using primers 
esigned with MethPrimer ( http: // www.urogene.org / methprimer / 
ndex1.html ) SYNP1P-U2F: 5 ′ -TGGTTTAGTTGGATTGTATTATATGG-3 ′ 
nd SYNP1P-U2R: 5 ′ -CTCCCGCTACAAACTAAAACAA-3 ′ , PCR was car- 
ied in a total volume of 10 ml containing10 ng bisulﬁte treated DNA, 
 pmol of each primer, 0.5 mM dNTP and 0.625 U PfuTurbo C x HotStart 
NA polymerase (Agilent Technologies). 
PCR conditions were: 95 ◦C for 2 min, 30 cycles of 95 ◦C for 30 s, 
2 ◦C for 30 s, 72 ◦C for 1 min, and an elongation step of 72 ◦C for
0 min. 
PCR products (104 bp) were gel-puriﬁed and cloned using the 
OPO TA Cloning Kit for Sequencing (Invitrogen, Denmark). For each 
issue 10 clones were randomly selected and plasmid DNA was 
repared. DNA was sequenced in both directions using the vector- 
peciﬁc primers TOPO-F: 5 ′ -AAGGGGGATGTGCTGC-3 ′ and TOPO-R: 
 
′ -GCTCACTCATTAGGCAC-3 ′ using the BigDye terminator cycle se- 
uencing kit and a 3730 Genetic Analyzer (Applied Biosystems). 
. Results 
.1. Characterization of porcine SYN1 genomic sequence 
A blast search in the Pig Genome v.10 sequence database 
 http: // www.animalgenome.org / blast / blast.php?bdb = pig10 ) using 
he porcine SYN1 cDNA sequence (GenBank: NM 001141988 ) re- 
ealed a 53 kb sequence covering the entire SYN1 gene (GenBank: 
N673714 ). The intron–exon structure is presented in Table S1 . The 
orcine SYN1 gene is composed of 13 exons with very non-uniform 
izes ranging from 58 to 610 nucleotides ( Table S1 ). All the observed 
plice acceptor and donor sites were in accordance with the consen- 
us GT–AG rule ( Table S1 ). The genomic organization of SYN1 genes 
eems to be well conserved. All exons in the porcine SYN1 gene, ex- 
ept for exon 12, have the same length of coding sequence as those of 
he human SYN1 sequence [ 41 ]. The additional 21 nucleotides found 
n the porcine sequence (exon 12) have been documented earlier [ 34 ]. 
n addition, the lengths of most introns of the porcine SYN1 gene were 
omparable to the human counterparts. Similar to human SYN1 , the 
orcine SYN1 exon13 also contains two splice acceptor sites [ 1 ]. The 
wo different AG splice acceptor sequences are localized at positions 
0753 and 50793, respectively, in the deposited SYN1 sequence (Gen- 
ank: JN673714 ) and give rise to messages for SYN1a and SYN1b as 
hown in Fig. 1 . This particular splice mechanism of SYN1 is conserved 
etween the pig, human, bovine and rat mRNAs. 3.2. Sequence analysis of the SYN1 promoter 
We have PCR ampliﬁed, cloned and sequenced a 1226 bp frag- 
ment of the 5 ′ ﬂanking region / putative promoter of the porcine SYN1 
gene (GenBank: GQ168794 ). Aligning of the obtained nucleotide se- 
quence, trimmed at the 3 ′ end to a total of 1208 bp, with the human 
SYN1 promoter ( Fig. 2 ) revealed an overall identity of 79%. The degree 
of homology decreased with increasing distance in the 5 ′ direction 
from the start codon illustrated by a 91% identity of the 3 ′ termi- 
nal 366 bp ( −233 bp from the putative transcription start site (TSS)). 
The TSS of porcine SYN1 was predicted by comparison with the hu- 
man SYN1 mRNA sequence (GenBank Access. No. M55301 ). Hence, the 
nucleotide in position + 1 is an A which is common in vertebrates. 
In addition to the nucleotide substitutions, a number of indels are 
present exclusively within the 5 ′ terminal less conserved segment of 
842 bp. 
The nucleotide sequence of the genomic DNA 1226 bp up- 
stream of the transcription start site (TSS) of the porcine SYN1 
gene was analyzed for transcription factor binding sites using 
the computer-based MatInspector and TFSEARCH program ( http: / 
/ molsun1.cbrc.aist.go.jp / htbin / nph-tfsearch ) and using the transfac 
database. The analysis revealed neither a TATA box nor any CCAAT 
box in the 1208 bp 5 ′ -ﬂanking sequence of porcine SYN1 . Instead, the 
SYN1 promoter was found to be of a GC-rich type with a pronounced 
GC-content of 76% within the 3 ′ terminal 366 bp ( −233 bp from the 
putative TSS) as compared to the overall GC-content of 62%. Further- 
more, the distance from the putative TSS to the translation initiation 
codon (position 1232–1234 in Fig. 2 ) was 130 bp accounting for the 5 ′ 
untranslated region of the SYN1 mRNA. The putative TSS and the tran- 
scription factor binding elements, Sp1 (of which ﬁve are present) and 
CRE (cAMP responsive element), identiﬁed in the human promoter are 
found to be completely conserved in the porcine promoter. Moreover, 
a fourth element of 21 bp, NRSE (neuron restrictive silencer element) 
also named the RE1-silencing transcription factor / neuron-restrictive 
silencer factor (REST / NRSF), involved in limiting gene expression to 
neurons, was found in three positions in the porcine SYN1 promoter. 
The sequences of the RE1 elements within the SYN1 promoter are 
highly conserved between pig and human. 
In conclusion, a high degree of sequence homology between the 
porcine and human SYN1 promoters was demonstrated. Importantly, 
transcription factor binding elements, the sequences surrounding the 
TSS, and the absence of TATA- and CAAT boxes were conserved in the 
porcine promoter. The high sequence similarity between human and 
porcine SYN1 could indicate the existence of similar mechanisms for 
regulation of expression. 
3.3. The SYN1 gene localises to chromosome X 
Recently, we have used Blat software to localize the SYN1 gene 
in the Sus scrofa 10.2 genome [ 42 ]. The SYN1 gene maps to SsChrX: 
47,336,723–47,388,638 ( Table 1 ). The human and mouse SYN1 genes 
have been mapped to the X chromosomes of these species [ 43 , 44 ]. 
3.4. SYN1 is abundantly expressed prenatally 
The expression level and pattern of SYN1 mRNA were investigated 
in various porcine brain tissues (FCO, CBE, BST, HIP, and BSG), at var- 
ious prenatal times (60, 80, 100, and 115 days of gestation), and in 
technical and biological triplicates in a semi-quantitative PCR assay 
relative to GAPDH expression. The speciﬁcity of the separate reverse 
primers discriminating between the isoforms a and b of the SYN1 
transcript was validated by electrophoretic determination of ampli- 
con length difference prior t the expression analysis (data not shown). 
Both SYN1a and SYN1b are expressed in all ﬁve brain tissues at 
all developmental stages examined even as early as 60 days of ges- 
tation ( Fig. 3 ). However, for both SYN1a and SYN1b transcripts there 
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Fig. 2. Alignment of the porcine and human (GenBank: M55301) SYN1 promoters using ClustalX2. Extensive homology is observed in particular in the 3 ′ end with the start codon 
(marked with a box and an ‘M ’ ), around the putative transcription start site (indicated by an arrow), and within the regulatory elements NRSE / REST, Sp1, and CRE (marked with 
boxes). The nucleotide A at position −230 mutagenized to a C in the experiments with transgenic zebraﬁsh is underlined. 
Table 1 
Methylation status of the porcine SYN1 gene in liver and brain (Sus scrofa 10.2). 
Gene Length (bp) Chr. Start End Tissue 
Methylated 
reads Total reads 
Methylation 
percentage 
SYN1 51,915 X 47,336,723 47,388,638 Brain 5232 7948 66 
Liver 14,021 25,540 55 
pSYN1 a 113 X 47,336,576 47,336,689 Brain 2 275 0 
Liver 2 1453 0 
a Methylation status of a discrete sequence of the of SYN1 promoter in liver and brain (Sus scrofa 10.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 are a considerable degree of heterogeneity among animals which is
reﬂected by the standard deviations. Compared to the constitutive
GAPDH expression, the levels of SYN1a ranged from 0.32 to 1.56 and
of SYN1b from 0.27 to 1.35. Also, the SYN1 expression developed dif-
ferently over time in the investigated tissues. 
In FCO and CBE, the SYN1 mRNA expression levels were signiﬁ-
cantly higher at day 100 and 115 of gestation compared to day 60 and
80 ( SYN1 a: FCO, P ≤ 0.001 and CBE, P ≤ 0.006; SYN1b : FCO, P ≤ 0.001
and CBE P ≤ 0.009) yielding an increase of 1.5–2 fold in level of ex-
pression. Moreover, there is no differential expression of any of thevariants neither in FCO nor in CBE between day 60 and 80 of gestation
( SYN1a : FCO, P = 0.39 and CBE, P = 0.24; SYN1b : FCO, P = 0.06 and CBE,
P = 0.46) and day 100 and 115 of gestation ( SYN1a : FCO, P = 0.32 and
CBE, P = 0.60; SYN1b: FCO, P = 0.68 and CBE, P = 0.53). The tendency
of an increase in expression level of the SYN1 messenger variants
over time is also present in HIP. Here the signiﬁcant up-regulation
is present between day 60 and 80 of gestation and between day 100
and 115 of gestation ( SYN1a : P ≤ 0.001 and P ≤ 0.001, respectively;
SYN1b : P ≤ 0.001 and P < 0.000, respectively). For BST and BSG, the
level of SYN1 expression, as in HIP, also increases between day 60 and
416 Claus Hedegaard et al. / FEBS Open Bio 3 (2013) 411–420 
Fig. 3. Analysis of endogenous porcine SYN1a and SYN1b expression levels by qPCR normalized to GAPDH expression. Five tissues, frontal cortex (FCO), cerebellum (CBE), brain stem 
(BST), hippocampus (HIP), and basal ganglia (BSG), at four different prenatal times (embryonic day 60, 80, 100, and 115), and in biological triplicates were included. Statistically 
signiﬁcant different expression levels were indicated by connective lines. 
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Fig. 4. Detection of the SYN1 transgene in genomic DNA puriﬁed from tail cuts of two 
non-transgenic zebraﬁsh (lanes 1 and 2 from left) and seven transgenic zebraﬁsh (lanes 
3–9). (A) DNA construct used for transgenesis of zebraﬁsh. A modiﬁed construct with 
an A to C substitution (nucleotide position 847) in the NRSE element is shown by the 
asterisk. (B) Examination for presence of transgenes in injected zebraﬁsh. PCR reactions 
were performed using speciﬁc primer sets for the GFP gene sequence (upper panel) 
and the SYN1 promoter (middle panel). A β-actin speciﬁc primer set establishing the 
quality of the genomic DNA is shown in the lower panel. All of the potentially transgenic 
zebraﬁsh proved to contain the transgene being positive for both GFP (720-bp band) 
and SYN1 (576-bp band). A negative reagent control is shown in lane 10 and a DNA 
marker is seen in lane 11. As expected no transgene was detected in the non-transgenic 
zebraﬁsh. (C) GFP transcript analysis of transgenic zebraﬁsh by RT-PCR. All transgenic 
zebraﬁsh appear to express GFP transcript, although at different levels, whereas no 
expression is seen in wild-type ﬁsh. 0 of gestation ( SYN1a : BST, P = 0.038 and BSG, P = 0.008; SYN1b : 
ST, P = 0.036 and BSG, P = 0.003). However, in both tissues, except 
or BST SYN1b , there is a signiﬁcant decrease in the level of expression 
etween day 100 and 115 of gestation ( SYN1a : BST, P = 0.037 and BSG, 
 = 0.002; SYN1b : BSG, P = 0.002). In summary, expression of porcine 
YN1 mRNA was found in all investigated prenatal brain tissues and 
n considerable amounts reaching ∼1.5 times that of GAPDH but also 
ound to diverge substantially in time and between different tissues. 
n general, the expression levels of SYN1a and SYN1b were compara- 
le, albeit the level of SYN1b tends to be slightly lower than that of 
YN1a. 
.5. In vivo assessment of SYN1 promoter activity 
To assess promoter activity and speciﬁcity in vivo , we injected ze- 
raﬁsh embryos with a plasmid expressing GFP driven by a 1.2 kb 
ragment from the porcine SYN1 promoter. We made use of the Tol2 
ransposon system (ref: PMID: 19504063 ) enabling efﬁcient stable ge- 
omic integration allowing for increased rate of integration and re- 
uced non-speciﬁc expression compared to injection of a standard 
xpression plasmid [ 37 , 38 ]. The DNA construct used for ﬁsh transfor- 
ation is based on the pT2AL200R150G vector (kindly provided by 
oichi Kawakami, National Institute of Genetics, Japan) (ref: PMID: 
6959904 , PMID: 15239961 ). The ﬁnal construct, pT2AL:SYN1:GFP, 
sed for microinjection into fertilized zebraﬁsh eggs, is shown in Fig. 
 A. 
GFP positive injected embryos were raised to adulthood and ﬁn- 
lips were tested for the presence of the transgene by PCR analysis 
sing primer sets amplifying a sequence of the SYN1 promoter and 
he GFP coding sequence, respectively. As shown in Fig. 4 B, ﬁnclips 
rom seven out of eleven adults with observed GFP expression in the 
ic stage contained the transgene. Very faint signals were obtained 
n transgenic zebraﬁsh Tg4 and Tg6 with PCR amplifying the GFP 
ransgene. Sequencing of the ampliﬁed DNA fragments conﬁrmed 
he identity of SYN1 and GFP . The copy number of the transgene SYN1 
n the transgenic zebraﬁsh was established by qPCR and found to be 
n the range 1–100 copies between individuals (data not shown). RT- 
CR analyses showed that GFP transcript was detected in most of the 
ransgenic ﬁsh although at a much lower level as compared to the level of β-actin ( Fig. 4 C). The low expression in certain transgenic ze- 
braﬁsh could eventually be explained by gene silencing. Sequencing 
of the RT-PCR product conﬁrmed the identity of GFP. Control reac- 
tions with RNA as a template in the PCR did not amplify any products 
(data not shown). 
To evaluate germ line transmission and GFP expression pattern in 
fully transgenic embryos, adults from the injected generation were 
Claus Hedegaard et al. / FEBS Open Bio 3 (2013) 411–420 417 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. F1 transgenic zebraﬁsh embryos expressing GFP under the regulation of the 
wild-type and NRSE-mutated porcine SYN1 promoters. Embryos oriented anterior to 
the left, dorsal to the top (A,B,D,E,F) or in an anterior view, dorsal to the top (C). 
All pictures are representative of GFP positive Tg(pSYN1:GFP) embryos ( n > 50) at 
72 hpf (A–C) or Tg(pSYN1-MUT:GFP) embryos ( n = 8) at 48 hpf (D–F). Non-speciﬁc 
autoﬂuorescence is observed from the yolk (Y) and pigment cells (PC). (A) Whole 
embryo view showing distinct but weak GFP expression in neuronal tissues including 
brain and spinal cord (SC). No expression is observed in non-neuronal tissues. (B) 
Close-up view showing GFP expression in midbrain (MB), hindbrain (HB), spinal cord, 
retina (R), trigeminal ganglion (TG), and posterior lateral line ganglion (LLG). Note the 
segmented signal in the hindbrain highlighting neurons of the rhombomeres, and the 
neuronal cell bodies discernible in the trigeminal and lateral line ganglia. Also, the 
bundle of axons projecting caudally from the lateral line ganglion are visible dorsal 
to the yolk sac. (C) Anterior view showing GFP expression in retina and optic chiasm 
(OC) and more weakly in the forebrain (FB). (D–F) The mutated promoter drives broad, 
possibly ubiquitous expression in zebraﬁsh embryos. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 crossed to wild type. In addition, we examined the expression pat-
tern of wild type and mutant (A-230C mutation in the NRSE element)
SYN1 promoter. Embryos with weak neuronal GFP signals were found
in the F1 generation descending from ﬁve pSYN1-injected individuals
( Fig. 5 A–C), and embryos with broad, possibly ubiquitous expression
was identiﬁed from a single founder injected with the NRSE-mutated
promoter construct ( Fig. 5 D–F). Expressing tissues in Tg(SYN1:GFP)
embryos include forebrain, midbrain, hindbrain, spinal cord, retina,
optic chiasm, trigeminal ganglion, posterior lateral line ganglion, and
olfactory neurons ( Fig. 5 B, C, and Supplementary Fig. 1 ). Note the
segmented signal in the hindbrain highlighting neurons of the rhom-
bomeres, the neuronal cell bodies discernible in the trigeminal and
lateral line ganglia, and the bundle of axons projecting caudally from
the lateral line ganglion ( Fig. 5 B). No expression was observed in non-
neuronal tissues. At 26 hpf, co-immunostaining for GFP and acety-
lated tubulin revealed that the promoter-driven GFP expression co-
localized with the neuronal marker in embryos injected with the
wild-type pSYN1:GFP construct ( Supplementary Fig. 2 ). Our in vivo
analysis of the NRSE mutated SYN1 promoter underlines the func-
tional requirement for this element, strongly suggesting that residue
A230 in the NRSE element is required for suppression of non-neuronal
expression. 
3.6. Methylation status of the SYN1 gene 
The methylation status of the porcine SYN1 gene was examined
by whole-genome bisulﬁte sequencing. Approximately 52 kb of the
coding sequence of the SYN1 gene was investigated for two different
porcine tissues: occipital cortex and liver. In occipital cortex 5232
methylated CpG reads were detected out of a total of 7948 reads
yielding a methylation degree of 66% ( Table 1 ). Similarly, in liver
tissue approx. 14,000 methylated reads were seen in a total of 25,500
reads, i.e. a methylation degree of 55%. In conclusion, the methylation
degree is signiﬁcantly higher in brain tissue compared with liver,
using the chi-square test ( p -value < 0.001). A 104 bp DNA stretch
in the SYN1 promoter was also examined for methylation. Only two
reads out of 275 were found to be methylated in brain tissue yielding
a methylation degree of 0.7%, i.e. very close to zero. Similarly, only
two reads out of 1453 reads were identiﬁed in liver tissue. 
To investigate whether the promoter of the porcine SYN1 pro-
moter is enriched for CpGs, and to determine its methylation status,
the overlap between these features was determined. The location
of CpGs in the promoter was identiﬁed using a sliding window op-
eration applying the Takai–Jones CpG criteria [ 45 ]. The Takai–Jones
criteria were as follows: length > 500 bp, GC > 55%, CpG observed /
expected ratio > 65%. In silico analysis of the porcine SYN1 promoter
sequence using MethPrimer ( http: // www.urogene.org / methprimer /
index1.html ) revealed one CpG island of approx. 660 nucleotides up-
stream of the ATG start codon ( Fig. 6 A). A discrete region of the SYN1
promoter sequence covering position −22 to −133 was selected for
bisulﬁte sequencing ( Fig. 6 B). This region is extremely GC-rich (76%;
44 G, 38C, 16A and 9T) and contains 12 CpG dinucleotides. Bisulﬁte
sequencing was carried out on DNA isolated from cerebellum and
frontal cortex samples from pig embryos at 60 days of gestation and
from a 12 year old pig. PCR was successfully ampliﬁed from bisul-
ﬁte treated DNA and sequenced. No methylation in the selected DNA
stretch of the SYN1 promoter was observed in the different tissues.
Comparison of methylation degree between 60 day old foetuses and a
12 year old sow revealed no methylation neither in FCO nor CBE in the
12 year old pig. Similarly, PCR ampliﬁcation of bisulfate treated DNA
samples from frontal cortex and cerebellum yielded no methylation
of CpGs. 4. Discussion 
The porcine orthologue of the SYN1 promoter was cloned, se-
quenced, and characterized with respect to regulatory elements, ge-
nomic localization, and expression activity. 
The porcine SYN1 promoter seems analogous to both the human
and murine promoters in all relevant aspects i.e. conservation of (i)
transcription factor interacting segments, (ii) the regions ﬂanking the
putative TSS, (iii) the sequence 429 bp upstream of the putative TSS
including GC-overrepresentation. Early studies on SYN1 gene struc-
ture and function reported only 225 bp 5 ′ to the TSS to act as a minimal
promoter and facilitate neuron-speciﬁcity in cell lines [ 41 , 46 , 47 ]. Sub-
sequently, a large promoter fragment of ∼4.3 kb was shown in vivo
to direct transgene expression almost exclusively to neuronal tissues
and also to correlate in a developmentally regulated way with endoge-
nous SYN1 expression [ 20 ]. A following comprehensive in vitro study
conﬁrmed the short 225 bp fragment harbouring the NRSE / REST to
be sufﬁcient to obtain neuronal speciﬁcity and further strongly in-
dicated the NRSE / REST to be solely responsible for generating the
speciﬁcity [ 14 ]. In addition, it was demonstrated that an even shorter
418 Claus Hedegaard et al. / FEBS Open Bio 3 (2013) 411–420 
Fig. 6. Bisulﬁte sequencing of a selected region of the porcine SYN1 promoter. (A) Schematic representation (not drawn to scale) of the porcine SYN1 gene exon–intron structure 
with CpG island location. Also, the bisulﬁte sequenced region of the promoter is indicated. (B) Sequence of the SYN1 promoter region selected for bisulﬁte sequencing. The analyzed 
sequence is shown in bold letters. Primer sequences are underlined. Twelve CpG dinucleotides are marked in blue letters. The transcription start site ( + 1) and the ATG start codon 
(bold capitalized letters) are also indicated. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.) 
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[99 bp fragment without the NRSE held constitutive promoter activ- 
ty in itself, but also that the segment immediately upstream of the 
RSE (422 bp in total) substantially enhanced the derived expression 
evels. In the present study we demonstrated that a substitution of a 
ingle nucleotide, A-230C in the NRSE changed the neuron-speciﬁcity 
f SYN1. Hence, the mutated nucleotide is required for suppression 
f non-neuronal expression. Recent studies by Paonessa et al. [ 47 ] 
ave revealed several cis -elements for the transcriptional activator 
p1 of which some are in close proximity to RE-silencing transcrip- 
ion factor (REST) binding motifs. Furthermore, it was demonstrated 
hat REST directly inhibits Sp1-mediated transcription which leads 
o SYN1 down-regulation [ 47 ]. A low level of REST allows a high sta- 
ility of Sp1 binding to GC boxes eventually leading to increases in 
YN1 transcription. A high level of REST in non-neuronal tissue might 
herefore explain low levels of SYN1 expression. 
Based on these results, the analogy of the porcine promoter, and 
he fact that the porcine promoter can be considered an evolutionary 
ntermediate between human and rodents, the porcine SYN1 pro- 
oter could consequently be expected to hold the equivalent ability 
f limiting gene expression strictly to cell populations of neuronal 
rigin when applied in transgenesis. Furthermore, in experiments 
tilising systems for gene transfer with limited capacity of transgene 
onstruct carriage, e.g. some viral vectors, a fragment of the porcine 
YN1 promoter of only 429 bp, or even shorter (233 bp), could advan- 
ageously be applied without compromising neuron-speciﬁcity. 
Using a cell line hybrid panel and a PCR selective for the SYN1 
romoter, the porcine SYN1 gene was reliably found to reside on 
hromosome X most likely in the region p11-13 (data not shown). 
his is in perfect accordance with the mapping of human and mouse 
YN1 to chromosome X p11.23 and chromosome X A1-4, respectively 
 44 ]. More recently, the human and murine genome projects have 
onﬁrmed the chromosomal localization ﬁtting the previously recog- 
ized phenomenon of the X chromosome to be largely conserved be- 
ween mammalian species in contrast to the autosomal counterparts 
 47 ]. In female mammals, one of the X chromosomes is inactivated during early embryonic development by among other mechanisms, 
DNA methylation of cytosine residues in the 5 ′ end of genes [ 48 , 49 ]. 
This holds implications for interpretation of SYN1 expression levels 
since the observed transcription levels originate from only one allele 
as compared to normally two for autosomally localized genes. 
By means of semi-quantitative real-time PCR, the expression levels 
of porcine SYN 1a and 1b were determined in various brain tissues at 
various prenatal times. Ranging from 0.27- to 1.56-fold of the GAPDH 
level, the SYN1 expression levels seem on the one hand to be surpris- 
ingly high bearing in mind that the transcription stems from a single 
allele, that the transcription of SYN1a and 1b has been assessed in- 
dividually, and that the SYN1 promoter is considered to be relatively 
weak [ 21 ]. On the other hand, SYN1 is very abundantly present in the 
central nervous system accounting for at least ∼0.5% of total protein 
in the brain [ 50 ]. In this context, therefore, it should be stressed that 
transcriptional levels of a gene and the translational levels of the cor- 
responding protein(s) do not necessarily correlate due to differential 
mRNA turnover, different translational efﬁciencies, RNA interference 
down-regulating effects, etc. Gene expression determined by qPCR 
on cDNA rather estimates the transcriptional levels i.e. the promoter 
strength and state of activation. 
Being neuronally expressed and targeting neurotransmitter re- 
leasing vesicles, SYN1 can be regarded as a marker of neuronal devel- 
opment, density, and integration. The foetal porcine brain becomes 
convoluted between embryonic day 60 and 80 but also develops be- 
yond that point in time. The signiﬁcant alterations in porcine SYN1 
expression observed during the embryonic stages in the various brain 
compartments most likely reﬂect the different biological functions of 
these compartments. Hence, CBE, BST, and BSG serve more basal pur- 
poses in nerve signal transmission and e.g. mediate controlled move- 
ments, seem to stagnate earlier developmentally, and may also have a 
lower neuronal density. On the other hand FCO and HIP present a pro- 
ﬁle of increasing prenatal SYN1 expression and likely also harbours 
relatively more neurons complying with the cognitive and memory 
functions of these tissues. The foetal porcine brain may thus provide 
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 an excellent model for studying prenatal brain and neuronal devel-
opment due to its size, availability, and recapitulation of diseases of
the human brain. 
The porcine SYN1 promoter was studied and evaluated for use in
generating neurodegenerative disease models. From conservation of
the nucleotide sequence in general and regulatory elements in partic-
ular, neuron-speciﬁcity can be anticipated also from the porcine SYN1
promoter. The transgene expression level attainable with this pro-
moter was estimated from quantiﬁcation of endogenous SYN1 mRNA
found to be at the same order of magnitude as the GAPDH expres-
sion. Taking into account that (i) SYN1 is expressed from only one
allele, (ii) both SYN1 transcripts are driven by the same promoter,
and (iii) proven enhancer elements (i.e. the WPRE) can be an integral
part of the transgene expression cassette, the porcine SYN1 promoter
presents as a good choice for establishing models of neurodegenera-
tive diseases. The neuron-speciﬁcity of the human SYN1 promoter has
been demonstrated in both earlier and recent studies [ 18 , 51 ]. A very
high speciﬁcity for neural expression was seen in rat neostriatum,
thalamus and neocortex after lentiviral transfer of pSYN1:GFP con-
structs [ 18 ]. Similarly, in rat hippocampal / cortical embryonic neurons
infected with lentivirus encoding pSYN1:GFP a neuron-speciﬁc ex-
pression was observed [ 51 ]. Neuron-speciﬁcity is presumably crucial
for precise mimicking of disorders like Alzheimer’s and Parkinson’s
disease by avoiding induction of pathological changes e.g. in glia as
in multiple system atrophy or in any other somatic cells that could
give rise to adverse phenotypes. Furthermore, a solid level of trans-
gene expression even prenatally is desirable since over-expression
of wild-type proteins is known solely to cause some degenerative
disorders and since the diseases are by nature slowly progressing. 
The presented SYN1 promoter could be a good candidate for at-
tempting to generate porcine models of human neurodegenerative
disorders. As a model species of human disorders including those
of neurodegenerative character, the pig is attracting attention for its
anatomic, physiologic, and genetic homology to man. 
We have analyzed the methylation status of the coding exons of
the porcine SYN1 gene and found signiﬁcant difference between brain
and liver with the highest degree of methylation in brain. A discrete
sequence of the porcine SYN1 promoter very close to the TSS was
found to be completely unmethylated in occipital cortex and liver. Oc-
cipital cortex expresses high levels of SYN1 transcript ( Fig. 3 ) whereas
no expression is found in liver. Similarly, no methylation was found
in other promoter regions of SYN1 in human and mouse [ 48 ]. A 104 bp
DNA stretch in the SYN1 promoter (see below) was also examined for
methylation. Only two CpGs of 1,453 were found methylated in liver,
yielding a methylation degree of 0%. Similarly, only two methylated
CpGs out of 275 were identiﬁed in brain (occipital cortex). According
to the classiﬁcation [ 52 ] this means an unmethylated status (U: < 20%).
It is estimated that between 60% and 80% of all CpGs are methylated in
mammals [ 53 , 54 ]. Unmethylated CpGs are often clustered in CpG is-
lands (CGIs) in promoter regions of mainly house-keeping genes [ 55 ].
Saxonov et al. [ 56 ] estimated that approx. 70% of promoters belong to
a class with high CpG content and around 30% are in a class with a CpG
content characteristic of the overall genome i.e. a low CpG content.
The linkage between gene promoter methylation and transcriptional
suppression has been well recognized for several years. Generalized,
genes with hypermethylated promoters are transcriptionally silent,
and DNA methylation gradually accumulates upon long-term gene
silencing [ 57 ]. In some cancers promoter CGIs become hypermethy-
lated resulting in transcriptional silencing of tumor suppressor genes.
From our data we conclude that the lack of expression of S YN1 in liver
is not the result of methylation of the promoter. DNA methylation
represents a mechanism of epigenetic regulation in eukaryotes that
is heritable thorough cell division. DNA methylation involves the ad-
dition of methyl groups to cytosine to form 5-methyl-cytosine and
occurs almost exclusively within the context of CpG dinucleotides.
It is estimated that 80% of all CpG sites in the human genome aremethylated. CpG islands contain clusters of CpG dinucleotides which
are often localized near the 5 ′ end of genes [ 58 , 59 ]. Methylation of
CpG dinucleotides within promoter CpG islands is rare in normal tis-
sue, but alterations in DNA methylation is frequent in diseases such as
diabetes, schizophrenia, multiple sclerosis, and cancer [ 60 , 61 ]. Also,
alterations in DNA methylation pattern is seen with increasing age
in mice and human [ 62 , 63 ]. Our methylation study was hampered
by the low number, one, of old pigs included. Therefore, the results
can only be regarded as preliminary and hypothesis generating and
studies of more animals are needed to certify the high methylation
level in old pigs. 
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